These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease. Allen KL; Waldvogel HJ; Glass M; Faull RL J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011 [TBL] [Abstract][Full Text] [Related]
3. Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice. Quéva C; Bremner-Danielsen M; Edlund A; Ekstrand AJ; Elg S; Erickson S; Johansson T; Lehmann A; Mattsson JP Br J Pharmacol; 2003 Sep; 140(2):315-22. PubMed ID: 12970075 [TBL] [Abstract][Full Text] [Related]
4. The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABA(A) receptors after chronic ethanol exposure. Warnault V; Houchi H; Barbier E; Pierrefiche O; Vilpoux C; Ledent C; Daoust M; Naassila M J Neurochem; 2007 Aug; 102(3):741-52. PubMed ID: 17442049 [TBL] [Abstract][Full Text] [Related]
5. Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranes. Cinar R; Freund TF; Katona I; Mackie K; Szucs M Neurochem Int; 2008 Jun; 52(8):1402-9. PubMed ID: 18407377 [TBL] [Abstract][Full Text] [Related]
6. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus. Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429 [TBL] [Abstract][Full Text] [Related]
8. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831 [TBL] [Abstract][Full Text] [Related]
9. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764 [TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation. Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE). Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911. Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746 [TBL] [Abstract][Full Text] [Related]
14. Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Adusei DC; Pacey LK; Chen D; Hampson DR Neuropharmacology; 2010 Sep; 59(3):167-71. PubMed ID: 20470805 [TBL] [Abstract][Full Text] [Related]
15. GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors. Mannoury la Cour C; Hanoun N; Melfort M; Hen R; Lesch KP; Hamon M; Lanfumey L J Neurochem; 2004 May; 89(4):886-96. PubMed ID: 15140188 [TBL] [Abstract][Full Text] [Related]
16. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia. Andersson M; Terasmaa A; Fuxe K; Strömberg I J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569 [TBL] [Abstract][Full Text] [Related]
17. Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission. Mikics E; Vas J; Aliczki M; Halasz J; Haller J Behav Pharmacol; 2009 May; 20(3):265-72. PubMed ID: 19421027 [TBL] [Abstract][Full Text] [Related]
18. Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Vinod KY; Arango V; Xie S; Kassir SA; Mann JJ; Cooper TB; Hungund BL Biol Psychiatry; 2005 Mar; 57(5):480-6. PubMed ID: 15737662 [TBL] [Abstract][Full Text] [Related]
19. Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice. Urigüen L; Berrendero F; Ledent C; Maldonado R; Manzanares J Eur J Neurosci; 2005 Oct; 22(8):2106-10. PubMed ID: 16262648 [TBL] [Abstract][Full Text] [Related]
20. Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists. Klein RL; Mascia MP; Harkness PC; Hadingham KL; Whiting PJ; Harris RA J Pharmacol Exp Ther; 1995 Sep; 274(3):1484-92. PubMed ID: 7562525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]